BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

BRL 17421 is a new semisynthetic beta-lactam antibiotic with an unusual spectrum of antibacterial activity. The compound exhibits exceptional stability to a wide range of bacterial beta-lactamases and is active against the majority of Enterobacteriaceae, including strains highly resistant to many of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Slocombe, B, Basker, M J, Bentley, P H, Clayton, J P, Cole, M, Comber, K R, Dixon, R A, Edmondson, R A, Jackson, D, Merrikin, D J, Sutherland, R
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1981
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC181629/
https://ncbi.nlm.nih.gov/pubmed/6974539
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi